- The Wall Street Journal•36 minutes ago
A trio of pharmaceutical companies is financing an effort by Aquinnah Pharmaceuticals Inc. to use a new approach to tackling neurological diseases that have long frustrated drugmakers.
- Market Realist•5 hours ago
Bristol-Myers Squibb (BMY) is expected to report a rise of ~8% to $4.7 billion in its 1Q17 earnings on April 27, 2017.
- Market Realist•6 hours ago
Bristol-Myers Squibb is set to release its 1Q17 earnings on April 27, 2017. Analysts expect EPS (earnings per share) of $0.74 and revenue of $4.7 billion for the company in 1Q17.
BMY : Summary for Bristol-Myers Squibb Company Co - Yahoo Finance
Bristol-Myers Squibb Company (BMY)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||53.65 - 54.32|
|52 Week Range||46.01 - 77.12|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||20.35|
|Dividend & Yield||1.56 (2.95%)|
|1y Target Est||N/A|